Tags

Type your tag names separated by a space and hit enter

Use of anthrax vaccine in response to terrorism: supplemental recommendations of the Advisory Committee on Immunization Practices.
MMWR Morb Mortal Wkly Rep. 2002 Nov 15; 51(45):1024-6.MM

Abstract

In December 2000, the Advisory Committee on Immunization Practices (ACIP) released its recommendations for using anthrax vaccine in the United States. Because of recent terrorist attacks involving the intentional exposure of U.S. civilians to Bacillus anthracis spores and concerns that the current anthrax vaccine supply is limited, ACIP developed supplemental recommendations on using anthrax vaccine in response to terrorism. These recommendations supplement the previous ACIP statement in three areas: use of anthrax vaccine for pre-exposure vaccination in the U.S. civilian population, the prevention of anthrax by postexposure prophylaxis (PEP), and recommendations for additional research related to using antimicrobial agents and anthrax vaccine for preventing anthrax

Authors

Pub Type(s)

Guideline
Journal Article
Practice Guideline

Language

eng

PubMed ID

12458919

Citation

Centers for Disease Control and Prevention (CDC). "Use of Anthrax Vaccine in Response to Terrorism: Supplemental Recommendations of the Advisory Committee On Immunization Practices." MMWR. Morbidity and Mortality Weekly Report, vol. 51, no. 45, 2002, pp. 1024-6.
Centers for Disease Control and Prevention (CDC). Use of anthrax vaccine in response to terrorism: supplemental recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep. 2002;51(45):1024-6.
Centers for Disease Control and Prevention (CDC). (2002). Use of anthrax vaccine in response to terrorism: supplemental recommendations of the Advisory Committee on Immunization Practices. MMWR. Morbidity and Mortality Weekly Report, 51(45), 1024-6.
Centers for Disease Control and Prevention (CDC). Use of Anthrax Vaccine in Response to Terrorism: Supplemental Recommendations of the Advisory Committee On Immunization Practices. MMWR Morb Mortal Wkly Rep. 2002 Nov 15;51(45):1024-6. PubMed PMID: 12458919.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Use of anthrax vaccine in response to terrorism: supplemental recommendations of the Advisory Committee on Immunization Practices. A1 - ,, PY - 2002/12/3/pubmed PY - 2002/12/11/medline PY - 2002/12/3/entrez SP - 1024 EP - 6 JF - MMWR. Morbidity and mortality weekly report JO - MMWR Morb Mortal Wkly Rep VL - 51 IS - 45 N2 - In December 2000, the Advisory Committee on Immunization Practices (ACIP) released its recommendations for using anthrax vaccine in the United States. Because of recent terrorist attacks involving the intentional exposure of U.S. civilians to Bacillus anthracis spores and concerns that the current anthrax vaccine supply is limited, ACIP developed supplemental recommendations on using anthrax vaccine in response to terrorism. These recommendations supplement the previous ACIP statement in three areas: use of anthrax vaccine for pre-exposure vaccination in the U.S. civilian population, the prevention of anthrax by postexposure prophylaxis (PEP), and recommendations for additional research related to using antimicrobial agents and anthrax vaccine for preventing anthrax SN - 0149-2195 UR - https://www.unboundmedicine.com/medline/citation/12458919/Use_of_anthrax_vaccine_in_response_to_terrorism:_supplemental_recommendations_of_the_Advisory_Committee_on_Immunization_Practices_ L2 - http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5145a4.htm DB - PRIME DP - Unbound Medicine ER -